Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: the DC Cohort
NCT ID: NCT01206920
Last Updated: 2024-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
15000 participants
OBSERVATIONAL
2011-01-31
2041-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
NCT03296202
Study of Women Who Have AIDS
NCT00001050
Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections
NCT00000858
Evaluation and Monitoring of Patients With HIV Infectionn
NCT00557570
Cardiovascular Risk Evaluation and Antiretrovirals in HIV
NCT01015092
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent.
* Patient is a minor who is consented by a parent or legal guardian.
Exclusion Criteria
* Minor children ages 12 through 17 who are unaware of their HIV status
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
George Washington University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amanda D. Castel
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amanda D Castel, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
George Washington University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente Mid-Atlantic States
Washington D.C., District of Columbia, United States
Unity Health Care
Washington D.C., District of Columbia, United States
MetroHealth
Washington D.C., District of Columbia, United States
Georgetown University
Washington D.C., District of Columbia, United States
La Clinica Del Pueblo
Washington D.C., District of Columbia, United States
Whitman-Walker Health
Washington D.C., District of Columbia, United States
Children's National Medical Center--Pediatric Clinic
Washington D.C., District of Columbia, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Washington Health Institute
Washington D.C., District of Columbia, United States
Family and Medical Counseling Service
Washington D.C., District of Columbia, United States
George Washington Medical Faculty Associates
Washington D.C., District of Columbia, United States
Howard University Hospital--Adult Clinic
Washington D.C., District of Columbia, United States
Howard University Hospital--Pediatric Clinic
Washington D.C., District of Columbia, United States
Veterans Affairs Medical Center
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jose Bordon, MD, PhD
Role: backup
Related Links
Access external resources that provide additional context or updates about the study.
DC Cohort Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
071029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.